HCMT
ADMA icon

Highland Capital Management (Tennessee)’s ADMA Biologics ADMA Stock Holding History

Highland Capital Management (Tennessee)’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-11,363
Closed -$227K – 376
2024
Q3 		$227K Buy
+11,363
New +$177K 0.01% 337

Other funds holding ADMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Highland Capital Management (Tennessee)'s ADMA Position: Q4 2024 in Review

Highland Capital Management (Tennessee) sold out of ADMA Biologics (ADMA) in Q4 2024, closing a stake of 11,363 shares — an estimated $227K sold.

Highland Capital Management (Tennessee) first reported a position in ADMA in Q3 2024 and held it in 1 quarter. The position peaked at $227K in Q3 2024. 321 funds tracked by Wall St. Rank hold ADMA as of Q4 2024.

  • Highland Capital Management (Tennessee) reported no remaining ADMA Biologics position as of Q4 2024 after selling out during the quarter.
  • Highland Capital Management (Tennessee) sold 11,363 ADMA Biologics shares in Q4 2024, an estimated $227K.
  • Highland Capital Management (Tennessee) first reported a position in ADMA Biologics in Q3 2024 and held it in 1 quarter.
  • Highland Capital Management (Tennessee)'s ADMA Biologics position peaked at $227K in Q3 2024.
  • 321 funds tracked by Wall St. Rank held ADMA Biologics as of Q4 2024.

Based on Highland Capital Management (Tennessee)'s 13F filing for Q4 2024, filed 23 Jan 2025.